Review
Published on 06 Oct 2022
Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1034903
- 3,864 views
- 6 citations
Type at least 3 characters
5,354 articles
Articles
Original Research
Published on 06 Oct 2022
Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.996308
- 4,522 views
- 3 citations
Original Research
Published on 06 Oct 2022
The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1028263
- 2,794 views
- 3 citations
Original Research
Published on 06 Oct 2022
Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1027154
- 2,971 views
- 2 citations
Editorial
Published on 06 Oct 2022
Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1045074
- 1,241 views
- 1 citation
Review
Published on 06 Oct 2022
Origin, activation, and targeted therapy of glioma-associated macrophages
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.974996
- 5,122 views
- 9 citations
Original Research
Published on 06 Oct 2022
Identification of a six-gene prognostic signature for bladder cancer associated macrophage
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.930352
- 5,966 views
- 6 citations
Original Research
Published on 06 Oct 2022
Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.948042
- 4,407 views
- 8 citations
Case Report
Published on 05 Oct 2022
Case report: CD19-directed CAR-T cell therapy combined with BTK inhibitor and PD-1 antibody against secondary central nervous system lymphoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.983934
- 3,603 views
- 1 citation
Original Research
Published on 05 Oct 2022
Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1012051
- 1,803 views
Review
Published on 05 Oct 2022
Stress and cancer: The mechanisms of immune dysregulation and management
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1032294
- 9,608 views
- 7 citations
Original Research
Published on 05 Oct 2022
Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.997765
- 9,211 views
- 11 citations
Original Research
Published on 05 Oct 2022
Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1002938
- 2,813 views
- 3 citations
Review
Published on 05 Oct 2022
Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.996145
- 4,605 views
- 9 citations
Original Research
Published on 04 Oct 2022
MiR-585-5p impedes gastric cancer proliferation and metastasis by orchestrating the interactions among CREB1, MAPK1 and MITF
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1008195
- 2,521 views
- 3 citations
Original Research
Published on 04 Oct 2022
The prognostic impact of the immune signature in head and neck squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1001161
- 3,669 views
- 3 citations